
Meconovit-G 300mg/500mcg Tablet
Marketer
Acto Pharma Pvt Ltd
Salt Composition
Gabapentin (300mg) + Methylcobalamin (500mcg)
Overview Meconovit-G 300mg/500mcg Tablet
Gabapentin/Pregabalin 300mg/500mcg tablets offer combined relief from neuropathic pain. This medication reduces pain signals by regulating calcium channels within nerve cells. Administer orally, with or without food, ideally at night. Consistent daily timing ensures stable drug levels. Follow your physician's prescribed dosage and duration. If a dose is missed, take it immediately upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation should only occur under medical supervision. Common adverse effects include nausea, swelling in the extremities, gait imbalance, visual blurring, fever, and involuntary eye movements (nystagmus). Dizziness and drowsiness may occur; avoid driving or mentally demanding tasks until effects are known. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor. Disclose pregnancy, pregnancy plans, or breastfeeding before starting treatment. While generally compatible with other medications, interactions with some drugs (including antacids and alcohol) can alter its efficacy and increase adverse reactions.
Uses of Meconovit-G 300mg/500mcg Tablet
Managing neuropathic pain
Major Benefits of Meconovit-G 300mg/500mcg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the 300mg/500mcg Meconovit-G tablet whole; avoid chewing, crushing, or fracturing it. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Meconovit-G 300mg/500mcg Tablet:
- Dizziness
- Sleepiness
- Tiredness
- Uncoordinated body movements
How to use Meconovit-G 300mg/500mcg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Meconovit-G 300mg/500mcg tablets can be consumed with or without food, though consistent timing is recommended.
How Meconovit-G 300mg/500mcg Tablet works:
Each Meconovit-G 300mg/500mcg tablet unites Gabapentin and Methylcobalamin to alleviate neuropathic pain. Gabapentin, an alpha-2-delta ligand, reduces pain signals by regulating nerve cell calcium channels. Methylcobalamin, a B vitamin variant, supports myelin production, safeguarding nerve fibers and aiding damaged nerve cell repair. This dual action provides effective neuropathic pain relief.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Meconovit-G 300mg/500mcg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Meconovit-G 300mg/500mcg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Lactation and Meconovit-G 300mg/500mcg tablets appear compatible. Available human data indicates minimal infant risk. Postnatal observation for drowsiness and increased weight is recommended.
DrivingUNSAFE
Taking Meconovit-G 300mg/500mcg tablets might cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Meconovit-G 300mg/500mcg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Meconovit-G 300mg/500mcg Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Meconovit-G 300mg/500mcg Tablet :
Should you forget a Meconovit-G 300mg/500mcg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Meconovit-G 300mg/500mcg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
